Amato MP - Search Results

1

Immunomodulatory therapies delay disease progression in multiple sclerosis.

Bergamaschi R, Quaglini S, Tavazzi E, Amato MP, Paolicelli D, Zipoli V, Romani A, Tortorella C, Portaccio E, D'Onghia M, Garberi F, Bargiggia V, Trojano M. Bergamaschi R, et al. Among authors: amato mp. Mult Scler. 2016 Nov;22(13):1732-1740. doi: 10.1177/1352458512445941. Epub 2012 May 31. Mult Scler. 2016. PMID: 22653657

2

The Multiple Sclerosis Cooperative Etiological Study in Italy: preliminary analysis of CSF findings.

Trojano M, Logroscino GC, Pisicchio L, Rosato A, Bordo B, Citterio A, Amato MP, Livrea P. Trojano M, et al. Among authors: amato mp. Ital J Neurol Sci. 1987 Jun;Suppl 6:71-6. Ital J Neurol Sci. 1987. PMID: 3654180

3

The costs of multiple sclerosis: a cross-sectional, multicenter cost-of-illness study in Italy.

Amato MP, Battaglia MA, Caputo D, Fattore G, Gerzeli S, Pitaro M, Reggio A, Trojano M; Mu. S. I. C. Study Group. Amato MP, et al. J Neurol. 2002 Feb;249(2):152-63. doi: 10.1007/pl00007858. J Neurol. 2002. PMID: 11985380

4

Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis.

De Stefano N, Bartolozzi ML, Nacmias B, Zipoli V, Mortilla M, Guidi L, Siracusa G, Sorbi S, Federico A, Amato MP. De Stefano N, et al. Among authors: amato mp. Arch Neurol. 2004 Apr;61(4):536-40. doi: 10.1001/archneur.61.4.536. Arch Neurol. 2004. PMID: 15096402

5

Changes in neuropsychological test performance over the workday in multiple sclerosis.

Beatty WW, Goretti B, Siracusa G, Zipoli V, Portaccio E, Amato MP. Beatty WW, et al. Among authors: amato mp. Clin Neuropsychol. 2003 Nov;17(4):551-60. doi: 10.1076/clin.17.4.551.27942. Clin Neuropsychol. 2003. PMID: 15168919

6

European validation of a standardized clinical description of multiple sclerosis.

Amato MP, Grimaud J, Achiti I, Bartolozzi ML, Adeleine P, Hartung HP, Kappos L, Thompson A, Trojano M, Vukusic S, Confavreux C; Evaluation of the EDMUS system (EVALUED) Study Group. Amato MP, et al. J Neurol. 2004 Dec;251(12):1472-80. doi: 10.1007/s00415-004-0567-0. J Neurol. 2004. PMID: 15645346

7

Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta.

Annunziata P, Giorgio A, De Santi L, Zipoli V, Portaccio E, Amato MP, Clerici R, Scarpini E, Moscato G, Iudice A, Vacca G, Orefice G, Morra VB, Maimone D. Annunziata P, et al. Among authors: amato mp. J Neurol Sci. 2006 May 15;244(1-2):97-102. doi: 10.1016/j.jns.2006.01.004. Epub 2006 Feb 13. J Neurol Sci. 2006. PMID: 16473370

8

Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort.

Amato MP, Zipoli V, Goretti B, Portaccio E, De Caro MF, Ricchiuti L, Siracusa G, Masini M, Sorbi S, Trojano M. Amato MP, et al. J Neurol. 2006 Aug;253(8):1054-9. doi: 10.1007/s00415-006-0161-8. Epub 2006 Apr 11. J Neurol. 2006. PMID: 16609810

9

Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment.

Portaccio E, Amato MP, Bartolozzi ML, Zipoli V, Mortilla M, Guidi L, Siracusa G, Sorbi S, Federico A, De Stefano N. Portaccio E, et al. Among authors: amato mp. J Neurol Sci. 2006 Jun 15;245(1-2):195-9. doi: 10.1016/j.jns.2005.07.019. Epub 2006 Apr 24. J Neurol Sci. 2006. PMID: 16631794

10

Are there protective treatments for cognitive decline in MS?

Amato MP, Portaccio E, Zipoli V. Amato MP, et al. J Neurol Sci. 2006 Jun 15;245(1-2):183-6. doi: 10.1016/j.jns.2005.07.017. Epub 2006 Apr 27. J Neurol Sci. 2006. PMID: 16643949 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

437 results

Search Page

Filters